Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
[Undergraduate medical education. Students' perspective and medical school policy].

Presse medicale (Paris, France : 1983)

Vinceneux P, Carbon C, Pouchot J, Crickx B, Maillard D, Regnier B, Desmonts JM, Fontaine A.
PMID: 11089505
Presse Med. 2000 Oct 14;29(30):1654-7.

OBJECTIVES: Student attendance to lectures in French medical schools is often poor. We surveyed undergraduate medical students in our medical school, repeating a similar survey conducted ten years earlier. The results are presented with the conclusions of the faculty...

Cite
Vinceneux P, Carbon C, Pouchot J, et al. L'enseignement du deuxième cycle des études médicales. Point de vue des étudiants et politique pédagogique. [Undergraduate medical education. Students' perspective and medical school policy]. Presse Med. 2000;29(30):1654-7
Vinceneux, P., Carbon, C., Pouchot, J., Crickx, B., Maillard, D., Regnier, B., Desmonts, J. M., & Fontaine, A. (2000). L'enseignement du deuxième cycle des études médicales. Point de vue des étudiants et politique pédagogique. [Undergraduate medical education. Students' perspective and medical school policy]. Presse medicale (Paris, France : 1983), 29(30), 1654-7.
Vinceneux, P, et al. "L'enseignement du deuxième cycle des études médicales. Point de vue des étudiants et politique pédagogique." [Undergraduate medical education. Students' perspective and medical school policy]. Presse medicale (Paris, France : 1983) vol. 29,30 (2000): 1654-7.
Vinceneux P, Carbon C, Pouchot J, Crickx B, Maillard D, Regnier B, Desmonts JM, Fontaine A. L'enseignement du deuxième cycle des études médicales. Point de vue des étudiants et politique pédagogique. [Undergraduate medical education. Students' perspective and medical school policy]. Presse Med. 2000 Oct 14;29(30):1654-7. French. PMID: 11089505.
Copy Download .nbib Format: NLM
[Bispecific antibodies targeting CD3 in oncology and hematology].

Bulletin du cancer

Vanacker H, Vinceneux A, Nicolas-Virelizier E, Brahmi M, Cassier PA.
PMID: 34920802
Bull Cancer. 2021 Oct;108(10):S181-S194. doi: 10.1016/j.bulcan.2021.06.003.

Bispecific therapies targeting CD3, so-called T-cell engagers (TCE), belong to the new spectrum of anti-tumor immunotherapies stimulating T-lymphocytes. TCE are unique constructs targeting the MHC-independent CD3 epsilon subunit (CD3e) and a tumor antigen. To date, only blinatumomab have reached...

Cite
Vanacker H, Vinceneux A, Nicolas-Virelizier E, et al. Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bull Cancer. 2021;108(10):S181-S194doi: 10.1016/j.bulcan.2021.06.003.
Vanacker, H., Vinceneux, A., Nicolas-Virelizier, E., Brahmi, M., & Cassier, P. A. (2021). Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bulletin du cancer, 108(10), S181-S194. https://doi.org/10.1016/j.bulcan.2021.06.003
Vanacker, Hélène, et al. "Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie." [Bispecific antibodies targeting CD3 in oncology and hematology]. Bulletin du cancer vol. 108,10 (2021): S181-S194. doi: https://doi.org/10.1016/j.bulcan.2021.06.003
Vanacker H, Vinceneux A, Nicolas-Virelizier E, Brahmi M, Cassier PA. Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bull Cancer. 2021 Oct;108(10):S181-S194. doi: 10.1016/j.bulcan.2021.06.003. French. PMID: 34920802.
Copy Download .nbib Format: NLM
[Bispecific antibodies targeting CD3 in oncology and hematology].

Bulletin du cancer

Vanacker H, Vinceneux A, Nicolas-Virelizier E, Brahmi M, Cassier PA.
PMID: 34920802
Bull Cancer. 2021 Oct;108(10):S181-S194. doi: 10.1016/j.bulcan.2021.06.003.

Bispecific therapies targeting CD3, so-called T-cell engagers (TCE), belong to the new spectrum of anti-tumor immunotherapies stimulating T-lymphocytes. TCE are unique constructs targeting the MHC-independent CD3 epsilon subunit (CD3e) and a tumor antigen. To date, only blinatumomab have reached...

Cite
Vanacker H, Vinceneux A, Nicolas-Virelizier E, et al. Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bull Cancer. 2021;108(10):S181-S194doi: 10.1016/j.bulcan.2021.06.003.
Vanacker, H., Vinceneux, A., Nicolas-Virelizier, E., Brahmi, M., & Cassier, P. A. (2021). Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bulletin du cancer, 108(10), S181-S194. https://doi.org/10.1016/j.bulcan.2021.06.003
Vanacker, Hélène, et al. "Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie." [Bispecific antibodies targeting CD3 in oncology and hematology]. Bulletin du cancer vol. 108,10 (2021): S181-S194. doi: https://doi.org/10.1016/j.bulcan.2021.06.003
Vanacker H, Vinceneux A, Nicolas-Virelizier E, Brahmi M, Cassier PA. Anticorps bispécifiques ciblant CD3 en oncologie solide et onco-hématologie. [Bispecific antibodies targeting CD3 in oncology and hematology]. Bull Cancer. 2021 Oct;108(10):S181-S194. doi: 10.1016/j.bulcan.2021.06.003. French. PMID: 34920802.
Copy Download .nbib Format: NLM
Use of freeze-dried bone allografts in revision total hip arthroplasty.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Caltran M, Savornin C, Le Couteur P, Jouan P, Deroche P, Vinceneux JF, Barnouin L.
PMID: 27476178
Eur J Orthop Surg Traumatol. 2002 Dec;12(4):186-91. doi: 10.1007/s00590-002-0051-4. Epub 2002 Dec 17.

Acetabular loosenings with severe bone loss require a large amount of graft material to fill the defect. Although all donors are systematically subjected to serologic screening, bone allografts that are chemically processed, freeze-dried, and radiosterilized ensure a higher level...

Cite
Caltran M, Savornin C, Le Couteur P, et al. Use of freeze-dried bone allografts in revision total hip arthroplasty. Eur J Orthop Surg Traumatol. 2002;12(4):186-91doi: 10.1007/s00590-002-0051-4.
Caltran, M., Savornin, C., Le Couteur, P., Jouan, P., Deroche, P., Vinceneux, J. F., & Barnouin, L. (2002). Use of freeze-dried bone allografts in revision total hip arthroplasty. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 12(4), 186-91. https://doi.org/10.1007/s00590-002-0051-4
Caltran, Maurice, et al. "Use of freeze-dried bone allografts in revision total hip arthroplasty." European journal of orthopaedic surgery & traumatology : orthopedie traumatologie vol. 12,4 (2002): 186-91. doi: https://doi.org/10.1007/s00590-002-0051-4
Caltran M, Savornin C, Le Couteur P, Jouan P, Deroche P, Vinceneux JF, Barnouin L. Use of freeze-dried bone allografts in revision total hip arthroplasty. Eur J Orthop Surg Traumatol. 2002 Dec;12(4):186-91. doi: 10.1007/s00590-002-0051-4. Epub 2002 Dec 17. PMID: 27476178.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries